Is it possible to imagine a world free of Autism? Or practically a world where medical feats help treat autism back to normal? This illusion could be translated into reality. Thanks to research on regenerative medicines from cord blood cells. Recently, a group of researchers have been working to discover that umbilical cord blood cells might have a way to cure autism spectrum disorder (ASD). It has been noted that cord blood may be instrumental in repairing the body in ASD, which holds even more promise for probable treatment.
Many Americans have turned to this to cure ASD in their children. The new US clinical trial is said to be the first to gain US Food and Drug Administration approval. Administered and led by Dr. Michael Chez, Director of Pediatric Neurology at Sutter Medical Center, Some time ago a team of researchers published the results of a Phase II Clinical Trial that analyzed the efficacy and safety of autologous cells from umbilical cord blood for autistic patients. children who implemented a double-blind placebo-controlled design. In 2017, these Duke University medical researchers also published a Phase I safety trial evaluating autologous cord blood in autistic children. The emphasis on cord blood cells as a potential cell therapy, coupled with favorable findings from previous clinical studies, promises a brighter future in the treatment of ASD. CBR in its initiative to explore the potential of stem cells has offered institutional funding for Stutter clinical investigators.
The scope of newborn stem cells
The emphasis on cord blood cells being effective in the treatment of ASD stems from their innate benefits. Umbilical cord blood cells have a number of benefits such as:
ยท Anti-inflammatory properties: Research has revealed that stem cells possess the ability to normalize inflammation and migrate to the site of neurological injury.
Safe and Available: Umbilical cord blood is easily collected when a baby is born and can be stored indefinitely for any future use by a close relative or the newborn donor.
Bystander Effect: Infused stem cells are said to secrete factors that regenerate the body’s innate healing mechanism into and around a surrounding tissue through paracrine signaling, which is also called the bystander effect.
Start of research on ASD
The first clinical investigation using umbilical cord blood that was previously collected from the autistic child was recently completed. Children between the age group 2 and 6 who had ASD were investigated for this study. The aim of this trial was to assess whether cord blood was a safe medium to use in these children and to record any health improvements that might occur within a year. This team of children received a dose of stem cells through an intravenous infusion and the effects were observed. This study laid the foundation for other advanced studies to begin in the future. He demonstrated that cord blood cells were a safe mode of therapy when transferred as an infusion. He also recognized certain symptoms that could have been influenced.
These clinical trials highlight the importance of storing a baby’s stem cells. It also offers valid reasons why families should spend the expensive amount on cord blood banking processes. The modern medicine scene is in a stage of continuous evolution. And research on cord blood cells continues to offer revolutionary new treatment options for a wide range of medical conditions previously thought to be incurable. Clinical trials involving the use of cord blood cells to cure type 1 diabetes, cerebral palsy, and stroke are already underway. The possibility that ASD can be treated with stem cells is a great help that the medical world can give to humanity.